It is a safe bet that anyone traveling to Jamaica on vacation is open to the experience of, if not directly looking for, an opportunity to legally consume cannabis. Cannabis tourism in Jamaica is taking off, as properties across the Caribbean island are highlighted for their ingenuity in the fast-growing industry. Coral Cove is the perfect example of one such retreat.
Originators of the cannabis tourism experience, Higher Way Travel carved out a niche by bringing cannabis tourists to Hawaii for the Cannabis Expo in 2017 and ensuing festivities. Run by April Black, wife of infamous pot personality Bobby Black, Higher Way Tours have since branched out into facilitating tourist experiences in Jamaica.
Coral Cove is off the proverbial beaten path. There are some unpaved roads and potholes on the way there, but the remoteness and seclusion of the location make it the antithesis of a tourist trap. The resort is named after the abundance of coral that is artfully incorporated into the masonry work on the property.
The retreat resides far away from prying eyes. People who want to walk around without winding up on social media or be gawked at by other guests will especially appreciate this homey hamlet, with its private, secluded waterfront cove. Although, the cove itself is heaven on Earth for aspiring influencers who are eager to snap selfies in exotic locales.
Continue Reading at Forbes
Coca-Cola is looking at pitching cans of cannabis-infused wellness drinks to consumers in the latest bid by a big beverage behemoth to tackle the budding market for potentially potent enhanced potables.
“Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world,” the company said in a statement issued in response to a report from the Canadian BNN Bloomberg new service.
BNN reported that Coca-Cola was in talks with cannabis producer Aurora Cannabis to make marijuana-infused wellness drinks. Aurora Cannabis did not confirm that it was in talks with Coke, but the company’s chief executive did acknowledge that it had been in conversation with several beverage makers over the last few months.
Drinks infused with either cannabinoid-like CBD, which has medicinal, pain-relieving qualities, and THC, which gets users high, have become popular in states in the U.S. where the drug is legalized and in Canada where it has been fully decriminalized nationally.
The experiments in better sales through new chemistry come at a time when demand for both beer and bubbly sodas is slowing. Beer is being supplanted by booze and wine among American consumers (or a rising number of teetotalers are eating into sales of both). Meanwhile, sugary drinks also have seen their popularity dwindle as new consumers reach for the kombucha rather than the Coke.
Continue Reading at TechCrunch
Under Ohio’s new medical marijuana law, which goes into effect on September 8, the Board’s clarification on CBD oil, which can derive from either marijuana or hemp, is illegal. The board says CBD oil must go through the same rigorous testing procedures and comply with the same rules as real cannabis.
CBD is not legal in all 50 states. According to the Agricultural Act of 2014 (AKA the farm bill), only CBD cultivated under state law “in which such institution of higher education or state department of agriculture is located, and such research occurs,” is legal. CBD that is not manufactured from hemp grown under a state pilot program or for academic research is not legal.
Additionally, according to Jo Ingles of WOSU public radio Ohio, “The board adds the only legal way to sell CBD is through a medical marijuana control program dispensary. The Ohio Department of Commerce approved 56 dispensary licenses, five of which are in Franklin County.”
Full article at Forbes
A public hearing will be held next month to take comments on a moratorium halting new cannabis operations in Columbia County.
Commissioners last month enacted the moratorium on applications for production, processing or retail operations. The moratorium did not affect the one retail cannabis store in the county or an indoor grow operation approved by the county hearing examiner before the moratorium was enacted.
The resolution for the moratorium stated the current county code governing recreational and medical cannabis operations “allows for too much public safety issues and concerns, disallows for appropriate moderation and is in need of complete revision to ensure only suitable development occurs.”
If your pup has long suffered from anxiety, you’ve probably tried every treatment option in the book — which might have left you wondering as an alternative, “Is CBD OK for dogs?” There’s evidence that cannabinoid oil, which is derived from the cannabis plant but has no THC in it, can help humans with everything from anxiety to pain management — so why not dogs?
According to PetMD, cannabis oil can treat a wide range of health conditions in dogs, including not just anxiety and stress, but also seizures, nausea, arthritis, back pain, and gastrointestinal issues. (Indeed, the FDA recently approved a CBD-based medication for the treatment of epilepsy in humans, so it’s not too far of a stretch to examine CBD oil as a treatment for seizures in dogs, too.) And yes, it’s safe for your pup; in fact, it even has a leg up on some traditional pet medications in that, when properly dosed, it doesn’t have any life-threatening side effects.
According to Mashable, BarkShop began offering health and wellness supplements for dogs in 2017 and started work developing dog-specific CBD supplements in January of 2018. They’re available in both treat form and straight extract; the treats can obviously be eaten as is (think of them as CBD gummies for pets), while the extracts can be mixed with food.
Research tested and sourced from “family farms in Colorado,” the supplements claim to be useful for everything from anxiety brought on by thunderstorms or car rides to relieving nausea and treating seizures.
Read more at Bustle
Another cannabis stock is gearing up to trade publicly on the Canadian Stock Exchange (CSE). Tree of Knowledge Inc. (TOK) is the latest company to apply for a listing application on the market, following a growing list that includes headline-making companies such as MedMen (CNSX:MMEN) and The Green Organic Dutchman (TSX:TGOD.
A group of business and medical professionals founded TOK in 2015 with the goal of building a trusted CBD product line. The company also has an advisory board with leaders from diverse sectors from medicine to professional sports. Since then, the company has expanded to three continents and has grown its brand of CBD products called EVRCBD—oils, capsules, tinctures and vape pens.
Courtland Capital and TOK announced their merger agreement in April. Courtland is in the process of forming a Nevada subsidiary company to merge with TOK, whereby TOK shareholders will receive Courtland common shares, owning approximately 88 percent of the outstanding undiluted Courtland shares. The company plans to delist from the TSX Venture Exchange and instead pursue the listing on the CSE. Courtland will change its name to TOK in the reverse merger.
TOK Chairman Michael Caridi explained that TOK and Courtland make a great partnership moving forward in their quest to becoming a medical cannabis industry leader. Caridi cites the sheer magnitude of the medical cannabis market, and looks forward to the “ability to mature and expand [their] reach into the markets [they] are in and plan on entering.”
Like many other fitness-minded young professionals, a 25-year-old Boston resident named Cameron adheres to a fairly typical pre-workout routine. There’s the 20 minutes of stretching, generally followed by some light cardio.
As marijuana legalization has pushed the drug further toward the mainstream — and a longstanding social stigma has begun to dissipate — more individuals are taking up before hitting the weight room, sports field, or mixed martial arts mat.
While the idea might seem inherently counterintuitive — weed, after all, is a substance more commonly paired with Doritos than deadlifts — there is a passionate contingent that swears by it.
“It’s a weird phenomenon, but it’s an increasingly common phenomenon,” says Peter Grinspoon, a primary care doctor at Massachusetts General Hospital and author of the book “Free Refills: A Doctor Confronts His Addiction.” “The fact that a lot of people are saying it helps them can’t be ignored.”
Research into marijuana’s benefits has been notoriously scant, due in large part to the drug’s federal classification as a Schedule 1 substance — meaning that, along with heroin, LSD, and ecstasy, it’s deemed to have “no currently accepted medical use and a high potential for abuse.” And the few studies that do exist offer relatively little insight into the drug’s effects during physical activity, beneficial or detrimental.
Read the full article at Boston Globe
Doctors have been warned against rushing to prescribe medical cannabis despite Australians’ acceptance of its use.
To date, the evidence on the effectiveness of medical cannabis remains “limited”, said Jennifer Martin and Associate Professor Yvonne Bonomo in an editorial for the Royal Australasian College of Physicians (RACP).
Published in the Medical Journal of Australia, the editorial says the usual regulatory processes designed to protect patients from potential serious harms caused by medicinal cannabinoids must be adhered to.
In Australia, medicinal cannabis is legal but patient access is still very difficult.
The Therapeutic Goods Administration (TGA) Special Access Scheme (SAS) provides patient access to cannabis on compassionate grounds without the usual quality and safety data requirements.
This means approval is granted on a case-by-case basis provided the correct documentation is given by the prescribing doctor, says Dr. John Lawson, a pediatric neurologist and conjoint senior lecturer at the University of New South Wales.
A recent trial published in The New England Journal of Medicine, led by Australian neurologist Professor Ingrid Scheffer, found cannabidiol – one of at least 113 compounds found in the cannabis plant – significantly reduced the severity and frequency of seizures in children with a rare, yet devastating form of epilepsy known as a Dravet syndrome.
Last year, the Medical Cannabis Council called for more robust research to be done to ensure patients greater access in the future.
Read the full article in The Guardian
In essence, San Francisco is resetting the clock on the War on Drugs, at least for cannabis. The city is expanding upon Proposition 64, the state law that went into effect this year that makes amnesty for weed-related crimes a condition for legalizing cannabis in California.
As incredibly progressive as that ordinance is, San Francisco is not alone in attempting to work racial equity into the new legalized cannabis landscape. Cities across California and other states are upping the racial equity quotient in various ways, in what looks like a race to the top for seeking true racially and economically inclusive outcomes. As city leaders scratch their heads over how to realize real racial equity in policymaking, the legalized weed experiment is acting as the test case and is already proving itself sticky enough that cities are almost competing to be the most weedfully woke.
It’s not just the historically uber-liberal Bay Area that’s embarking on this. Los Angeles also has a cannabis social equity program that prioritizes business permits for people with low incomes, who have lived in an area ravaged by the drug war, have criminal records (because of past weed prohibition), and who plan to hire at least half of their workforces from local residents. Both Oakland and L.A. are also prioritizing permits for people who don’t personally fall under this criteria but are willing to finance or lease space to applicants who do.
Despite the heavy regulation of the cannabis market at both the city and state level (and maybe the federal level if Senator Cory Booker has it his way), there has still been immense growth in revenue and profits in this field. According to the 2017 Cannabis Industry Annual Report, from New Frontier Data, “The legal cannabis market was worth an estimated $6.6 billion in 2016, and annual sales are projected to grow at a compound annual growth rate (CAGR) of 16% to reach more than $24 billion by 2025.” And that’s only based on the states where weed is currently legal.
Read the full article at CityLab
Spoiler alert for those attending the Winter Fancy Food Show today through Tuesday in San Francisco: There are no cannabis edibles on the trade-show floor. Cannabis cuisine is not the subject of any plenary panel.
In November, the Fancy Food Show’s parent, the Specialty Food Association (SPA), ranked cannabis number eight of the top-10 food trends to watch in 2018.
“As more states legalize recreational marijuana, the varieties of pot-enhanced food and beverage will increase,” the SPA’s Trendspotter Panel wrote last November. “Look out for continued interest and acceptance in a host of snacks, treats and beverages with a little something extra.”
Nielsen is vice president of trends and marketing at CCD Innovation, an Emeryville food, and beverage development agency. She’s attending the Fancy Food Show today through Tuesday at Moscone Center. As a member of the Specialty Food Association’s Trendspotters — an expert panel comprised of marketers, journalists, and other tastemakers — she’ll roam the Fancy Food Show trade-show floor looking for new and innovative products. There are no cannabis edibles at this year’s Fancy Food Show, but the SPA’s Trendspotters won’t have to go far to find them.
There are five retail cannabis stores reachable via short walk, taxi or rideshare. And many of the edibles on sale in these stores look like they might have sneaked over from the show.
Read more at GreenState
California has now joined a number of states changing their approach to marijuana, which marks exciting times for national drug reform. If you’re over the age of 21, it is now legal to grow up to six plants and possess up to an ounce (!) on your person.
While the state’s residents have already been celebrating the news, tracking down a spot to purchase your recreational weed may prove a little difficult in these early days.
However, this may not indicate the end of drug dealers pedaling marijuana, as taxes are expected to raise the retail cost of the pot up to 70 percent higher than the street price. Nonetheless, It’s a very, very happy new year for Californians.
Mike Tyson has been a boxer, an actor, a monologuist, and an animated detective, but now it looks like the former heavyweight champion wants to take a bite out of California’s new legal weed game.
According to the Blast, Tyson and two business partners—Robert Hickman and Jay Strommen—have plans to build a massive “cannabis resort” on 40 acres of desert land in California City. The trio broke ground on the property back in December and are getting things rolling now that California has officially legalized marijuana.
It seems like the rest of the Mojave Desert land, though, will earn Tyson Ranch its “resort” title. The Beast reports that there will be “premium ‘glamping’ campgrounds and cabins” for people to stay in, an amphitheater for live music, and a factory for marijuana edibles.
The resort’s land isn’t far from Edwards Air Force Base, and the Blast reports that the ranch will be staffed mostly by veterans and will be committed to helping those in the armed forces, as CBD, a marijuana compound that won’t get you high, has been used to treat PTSD.
Read more at Vice
Sometime soon in Massachusetts, you’ll be able to walk into a cafe, ask for a marijuana product, and consume it right there without heading home first.
The state agency responsible for regulating legalized marijuana approved a policy on Monday that will allow for such establishments, so-called “cannabis cafes,” to open — where one can buy a cannabis product and then legally consume it on the premises, just like buying a drink at a bar.
Like bartenders in restaurants in bars, marijuana servers must be trained properly. Such training will focus on helping them identify customers who are too intoxicated to be served more. The commission also agreed that businesses licensed to serve cannabis, should not be allowed to serve alcohol.
Cannabis proponents like Michael Latulippe are pleased with the prospect of on-premises cannabis businesses. Latulippe is a registered medical marijuana user and a member of the state’s Cannabis Advisory Board.
Public safety officials still have concerns. Walpole Police Chief John Carmichael is another member of the commission. He says its important regulations are put in place to prevent people from driving while under the influence of marijuana.
Read more at New England Public Radio
Several new rules and regulations for legal cannabis in Colorado have been finalized and will go into effect January 1, 2018, according to the Marijuana Enforcement Division. The MED had been holding stakeholder meetings and accepting public feedback on many of the proposed rules since September; they include updates to packaging regulations, a new state program for medical cannabis research and more.
Many of the new rules are a result of 2017’s legislative session, with amendments to existing laws and new bills forcing updates that affect both the industry workforce and consumers. HB 1034, HB 1261, SB 187 and SB 192 will change employee training methods, business location transfers, product contaminate testing, concentrate wholesalers and packaging and labeling.
Most of the rules were made to increase youth, consumer, and employee safety, the MED says, such as new packaging and labeling requirements that are designed to decrease interaction with minors.
The MED will continue to issue industry bulletins and tips for stakeholders on how to comply with the new rules as they go into effect.
Read the full article at West Word
A trade organization in the United Kingdom that oversees the rapidly expanding cannabidiol (CBD) and hemp market, has published a study that shows the use of CBD oil in the U.K. has doubled in a single year.
The Cannabis Trades Association U.K.’s (CTAUK) figures reveal 250,000 people are now using CBD oil to treat their health conditions. CTAUK added that the number of users is up from 125,000 last year, with approximately 1,000 new users each month.
In October 2016, the U.K. government recognized the medicinal value of CBD, stating the cannabinoid has “restoring, correcting, or modifying” properties. This admission has allowed suppliers to sell CBD by obtaining a medicinal license, which is a lengthy and strict process. Many retailers have been able to circumvent the process by selling CBD products as food supplements.
Most recently, the public debate around medical cannabis in the U.K. has seen a lot of attention, with a bill to legalize going through its first parliamentary reading Oct. 10 unopposed. That same day, a protest incited by a member of parliament and cannabis activist Paul Flynn took place in front of the Parliament building in London.
More of this news at Marijuana.com
Hyderabad: Cannabis oil was used by a 69-year-old woman to treat a breast tumour which was diagnosed by doctors in the West.
There have been testimonies which claimed cannabis oil helped cure cancer. According to researchers, cannabis compounds are found to kill malignant cells. However, trials have not yet been carried out on humans.
Dr. Srinivas C., a senior oncologist, said, “These methods have to be researched to be used at the clinical level. Currently, the protocols are chemotherapy, radiotherapy, surgeries and personalized treatment. There are claims made from time to time.”
Cannabis oil is sold legally in the west as a food supplement. Its medical use has not started. A senior oncologist, on condition of anonymity, said, “The integrated therapy, using the Ayurveda and the modern medicine, has started in certain hospitals in the state. It has been found that every human body requires a different set of medications, dosages, and protocols to treat cancer.”
More of this story at Deccan Chronicle
Cannabidiol, one of the active chemicals in marijuana, is having a moment. While the science remains inconclusive, there’s growing traction for its use as a therapeutic agent for cancer and schizophrenia, and for its inclusion within more cosmetic items, like CBD-infused bath bombs and acne creams. What makes CBD novel is that it, unlike THC, is a cannabinoid chemical that comes without the high — although as a fixture of a Schedule I drug, in some places, it still comes with the stigma.
In October, Isodiol International Inc.)), a company that claims it is “the largest global industrial source of CBD hemp oil worldwide,” announced its plan to release the market’s first CBD products derived from hops — the cone-shaped flowers responsible for flavoring and stabilizing beer.
While 29 states and the District of Columbia have legalized marijuana in some form, all cannabis extracts, including CBD, are still ruled federally as Schedule I substances. With the attorney general post belonging to Jeff Sessions, that ruling won’t likely change anytime soon. Hops, meanwhile, are legal everywhere.
As cannabidiol continues to be explored for its therapeutic potential as a treatment for disorders that include, but aren’t limited to, anxiety, schizophrenia, and cancer, it will be interesting to see whether other companies and universities follow Ursodiol in the study of CBD derived from hops. The illegality of cannabis has made it difficult for scientists to research its benefits, but hops could be a promising route when it comes to exploring how CBD can help people heal.
Read the full article at Inverse
A team of scientists from the American University of Beirut fed Nile tilapia fish pellets laced with cannabis oil to test whether the drug could make the fish reduce stress and grow faster.
These researchers noted that tilapia is farmed intensively, and in a bid to maximize the amount of product fish farmers can bring to market, some fish pens have become incredibly congested. Living in such close quarters can lead to all kinds of challenges for the fish, including reduced water quality, more incidences of disease, and increasing intraspecific interactions, which leads to stress.
As part of the trial, three diets were made to contain either soy oil, industrial hemp oil or cannabis oil and offered to tilapia for 8 weeks. At termination, survival, growth, feed conversion and blood parameters were assessed.
On the other hand, cannabis had no effect on blood cell counts, total plasma protein, hematocrit or lysozyme activity.
The results thus obtained suggest that cannabis does not improve the immune response of tilapia or body composition but does reduce growth rate by increasing metabolic rate.
Therefore, the Lebanese scientists found that the pot pellets did not quite have the mood-altering effect they had hoped for.
Continue Reading at Fish Info & Services Co.Ltd
Yvonne Delarosa Green was awarded the first cannabis business license for Los Angeles County for her dispensary 99 High Tide Collective in Malibu. The city and county of Los Angeles are expected to become the capital of cannabis once the state of California’s regulated adult-use market is up and running.
There is a great deal of confusion over the cannabis licenses in the city versus the county. Los Angeles, the city, hasn’t issued any licenses, and it is rumored that existing dispensaries will have to close until they receive the new 2018 license under the new regulations.
Keith Knox, chief deputy treasurer and tax collector for the county, confirmed that Los Angeles County administers some functions like business permits for three cities and Malibu is one of those three. However, Los Angeles County is banning marijuana for now, which makes the licensing in Malibu even more unique.
The mayor’s office in Malibu said in a statement:
“The City of Malibu’s Municipal Code allows for two medical marijuana dispensaries to operate within City limits. Two medical marijuana dispensaries have been in operation in the City for several years. Los Angeles County issues business licenses on behalf of the City of Malibu, and approved a business license for one of the two existing medical marijuana dispensaries today.”
Read the full article at Forbes
American Chemical Society’s ACS Omega has published a study which claims to be groundbreaking in terms of how we view a very specific type of cannabis consumption, the so-called cannabis oil dabbing.
The study which was published this month finds that dabbing cannabis oil through glass rigs may expose users to elevated toxin levels as compared to other methods, such as smoking dried cannabis or even vaping it for that matter.
In an effort to explain how the chemicals in concentrated cannabis break down under heat, a team of scientists from Portland State University has discovered that concentrates exposed to the high heat common to dab setups produced elevated levels of carcinogenic and toxic compounds.
Dabbing at low temperatures might be the way out
Researchers from PSU said that the key factor in which chemicals get released is the degree of heat used to activate cannabinoids in the oil.
Researchers also found that the higher the temperature that a substance’s flavoring terpenes are subjected to, the more carcinogens, toxins, and potential irritants are produced — meaning that you should dab on as low as possible temperatures.
Read the full article at Greencamp